Search results
FDA warns microdosing chocolate bars may lead to seizures, other illness
KIRO 7 Seattle-Tacoma· 14 minutes agoPeople across four states have fallen ill after eating Diamond Shruumz-brand microdosing chocolate...
Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know
Forbes· 12 hours agoA panel of experts advising the Food and Drug Administration could on Monday recommend Eli Lilly’s...
FDA panel reviews Eli Lilly Alzheimer's drug ahead of agency decision
Reuters via AOL· 5 hours ago(Reuters) -Outside advisers to the U.S. Food and Drug Administration are meeting on Monday to assess...
FDA and DOJ pledge more cooperation on illegal e-cigarettes ahead of congressional hearing
19 Action News Cleveland· 30 minutes agoThe Food and Drug Administration said it would launch a new task force on this issue with the...
Food recalls: Full list of products under warning
Newsweek· 4 hours agoFood and beverage recalls administered by the U.S. Food and Drug Administration (FDA) occur regularly, although some products warned ...
Eli Lilly Rises Again, As FDA Panel Mulls Biogen-Rivaling Alzheimer's Drug
Investor's Business Daily· 2 hours agoEli Lilly stock edged higher Monday as a panel of advisors to the Food and Drug Administration...
These microdosing chocolate bars are getting people seriously ill
The Independent via Yahoo News· 3 hours agoEight people became sick after eating Diamond Shruumz-brand Microdosing Chocolate Bars , prompting...
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.
Motley Fool via Yahoo Finance· 4 hours agoAfter an unexpected vote at the Food and Drug Administration (FDA) on June 4, shares of psychedelics...
FDA rescinds marketing ban on Juul vaping - KYMA
KYMA· 2 hours agoOn Thursday, the U.S. Food and Drug Administration (FDA) announced marketing denial orders for the company's products are rescinded.
Lilly's Alzheimer's drug faces delayed reckoning
Axios· 5 hours agoWhy it matters: Their conclusions could influence how the FDA treats future drugs that target proteins in the brain known as amyloid plaques that are...